Notice: This company has been marked as potentially delisted and may not be actively trading. Homology Medicines (FIXX) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period What Western medicine can learn from the ancient history of psychedelicsSeptember 13, 2024 | bbc.comOfficials in North Korea seek medicine for Kim Jong Un's health problems related to obesity, Seoul saysAugust 2, 2024 | nbcnews.comTrading was temporarily halted for "FIXX" at 07:03 PM with a stated reason of "News pending."March 26, 2024 | marketbeat.comHomology Medicines, Inc.: Homology Medicines Declares Distribution to Common StockholdersMarch 24, 2024 | finanznachrichten.deFIXX Homology Medicines, Inc.March 23, 2024 | seekingalpha.comHomology Medicines Declares Distribution to Common StockholdersMarch 18, 2024 | finance.yahoo.comHOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXXFebruary 27, 2024 | businesswire.comHomology Medicines Inc (FIXX)February 2, 2024 | investing.comHomology Medicines, Inc.: Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price DeficiencyJanuary 4, 2024 | finanznachrichten.deHomology Medicines gets non-compliance notice from NasdaqJanuary 4, 2024 | msn.comHomology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price DeficiencyJanuary 3, 2024 | finance.yahoo.comHomology Medicines Stock (NASDAQ:FIXX) Insider TradesDecember 27, 2023 | benzinga.comHomology Medicines Stock (NASDAQ:FIXX), Short Interest ReportDecember 27, 2023 | benzinga.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MIRO, SRC, PATI, FIXXNovember 21, 2023 | markets.businessinsider.comHOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXXNovember 17, 2023 | businesswire.comHOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXXNovember 17, 2023 | businesswire.comBig Pharma-backed startup to go public by merging with gutted HomologyNovember 17, 2023 | bizjournals.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Homology Medicines (FIXX), Align Tech (ALGN) and Calidi Biotherapeutics (CLDI)November 16, 2023 | markets.businessinsider.comHomology Medicines slumps after merger deal with Q32 BioNovember 16, 2023 | msn.comWhy Is Rare Disease Focused Homology Medicines Stock Trading Lower Today?November 16, 2023 | msn.comFIXX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Homology Medicines, Inc. Is Fair to ShareholdersNovember 16, 2023 | tmcnet.comHomology Medicines Shares Drop 38% After Buyout Offer From Q32 BioNovember 16, 2023 | marketwatch.comHomology Medicines To Merge With Q32 Bio; Homology Medicines Down In Pre-marketNovember 16, 2023 | markets.businessinsider.comQ32 Bio and Homology Medicines Announce Merger AgreementNovember 16, 2023 | finance.yahoo.comHomology Medicines, Inc.: Homology Medicines Reports Third Quarter 2023 Financial ResultsNovember 15, 2023 | finanznachrichten.deHomology Medicines GAAP EPS of -$0.57 misses by $0.15November 14, 2023 | msn.comHomology Medicines Reports Third Quarter 2023 Financial ResultsNovember 14, 2023 | finance.yahoo.comCan Homology Medicines (NASDAQ:FIXX) Afford To Invest In Growth?October 28, 2023 | finance.yahoo.comHomology Medicines, Inc.: Homology Medicines Reports Second Quarter 2023 Financial Results and Recent HighlightsAugust 15, 2023 | finanznachrichten.deHomology Medicines Reports Second Quarter 2023 Financial Results and Recent HighlightsAugust 14, 2023 | finance.yahoo.comHomology Medicines (FIXX) Price Target Decreased by 55.71% to 3.16August 3, 2023 | msn.comHomology lays off 80, explores sale, citing 'tough financing conditions'July 28, 2023 | bizjournals.comHomology (NASDAQ:FIXX) Mulls Strategic Options; Shares JumpJuly 28, 2023 | msn.comThe Latest Analyst Ratings for Homology MedicinesJuly 28, 2023 | markets.businessinsider.comHomology Medicines Announces Encouraging Initial Data from First Dose Level in the pheEDIT Trial Evaluating Gene Editing Candidate HMI-103 in Adults with Classical PKUJuly 28, 2023 | finance.yahoo.comHomology Medicines Announces Plan to Evaluate Strategic Options for the Company and its Genetic Medicines Programs, including HMI-103 Gene Editing Candidate for PKUJuly 28, 2023 | finance.yahoo.comTrading was temporarily halted for "FIXX" at 04:07 PM with a stated reason of "News pending."July 27, 2023 | marketbeat.comPhenylketonuria Drugs Market: Trends, Demand, Growth, Business Development, Analysis By 2029June 22, 2023 | marketwatch.comRobert W. Baird Keeps Their Buy Rating on Homology Medicines (FIXX)June 22, 2023 | markets.businessinsider.comHomology Medicines Announces First Data from IND-Enabling Studies with GTx-mAb Candidate HMI-104 for PNH, Which Demonstrated Sustained Expression of Functional C5mAb Levels, at the ASGCT Annual MeetingMay 16, 2023 | finance.yahoo.comHomology Medicines (FIXX) Gets a Hold from RBC CapitalMay 15, 2023 | markets.businessinsider.comHC Wainwright & Co. Reiterates Homology Medicines (FIXX) Buy RecommendationMay 15, 2023 | msn.comRobert W. Baird Sticks to Their Buy Rating for Homology Medicines (FIXX)May 15, 2023 | markets.businessinsider.comChardan Capital Maintains Homology Medicines (FIXX) Buy RecommendationMay 12, 2023 | msn.comCredit Suisse Reiterates Homology Medicines (FIXX) Neutral RecommendationMay 12, 2023 | msn.comCredit Suisse Keeps Their Hold Rating on Homology Medicines (FIXX)May 12, 2023 | markets.businessinsider.comHomology Medicines, Inc.: Homology Medicines Reports First Quarter 2023 Financial Results and Recent HighlightsMay 12, 2023 | finanznachrichten.deHomology Medicines Reports First Quarter 2023 Financial Results and Recent HighlightsMay 11, 2023 | technews.tmcnet.comHomology Medicines GAAP EPS of -$0.50 beats by $0.04, revenue of $0.8M misses by $0.21MMay 11, 2023 | seekingalpha.comHomology Medicines Announces Upcoming Presentations Highlighting its GeneticMay 3, 2023 | tmcnet.com Get Homology Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for FIXX and its competitors with MarketBeat's FREE daily newsletter. Email Address Tesla Execs are Freaking Out (Ad)It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss. Click here to get the details. FIXX Media Mentions By Week FIXX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FIXX News Sentiment▼0.000.46▲Average Medical News Sentiment FIXX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FIXX Articles This Week▼00▲FIXX Articles Average Week Get Homology Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for FIXX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Bicycle Therapeutics News Akebia Therapeutics News Spero Therapeutics News RAPT Therapeutics News Organon & Co. News Perrigo News Rhythm Pharmaceuticals News Apellis Pharmaceuticals News MoonLake Immunotherapeutics News Agios Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FIXX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Homology Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Homology Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FIXX Stock Alerts